Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Founded in 2012 by Aviva Lev-Ari, PhD, RN

Leaders in Pharmaceutical Business Intelligence (LPBI) Group was established in April 2012 with a clear mission: to create the highest-quality, curated scientific intelligence platform in the pharmaceutical and life sciences sectors.

What began as an open-access scientific journal focused on expert curation rapidly evolved into a comprehensive digital knowledge ecosystem. From 2012 to 2020 (Phase 1.0), the focus was on building a robust foundation through meticulous curation of peer-reviewed literature, resulting in thousands of high-value articles and the launch of the BioMed e-Series.

In 2021, LPBI entered Phase 2.0 — a strategic transformation toward AI-enabled intelligence. This period saw the development of the proprietary 14-part Composition of Methods (COM) — our “Tool Factory” for Health AI Analytics — along with the expansion of multimodal assets, including a growing Media Gallery, e-Proceedings, and the BioMed Audio Podcast Library.

Today, in 2026, LPBI Group stands as a debt-free, founder-led organization with a mature, interconnected portfolio of intellectual property assets. The journey from scientific curation to AI-ready intelligence has been deliberate, rigorous, and visionary — positioning LPBI Group as the cardinal resource for the next era of biomedical discovery.

For a detailed overview of this evolution, see: Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality https://pharmaceuticalintelligence.com/2026/01/12/evolving-lpbi-groups-portfolio-of-intellectual-properties-ip-from-2021-vision-to-2026-reality/

This Master Plan represents the culmination of decades of work and the beginning of a new chapter.